Ionizing Radiation Inhibits the PLK Cell Cycle Gene in a G2 Checkpoint-dependent Manner

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 555-562

  Ree, Anne Hansen ^a   Bratland, Åse ^a   Landsverk, Kirsti Solberg ^a   Fodstad, Øystein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; Cell cycle checkpoints; Ionizing radiation; Polo like kinase 1

Indexed keywords

BRCA1 PROTEIN; CELL CYCLE PROTEIN; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; POLO LIKE KINASE 1; PROTEIN; PROTEIN KINASE; PROTEIN P21; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRAIN; CELL STRAIN HCC1937; CELL STRAIN MCF 7; CELL STRAIN MCF 7 LCC2; CONTROLLED STUDY; DNA DAMAGE; ENZYME INHIBITION; GENE; GENE REPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IONIZING RADIATION; MITOSIS; MITOSIS INHIBITION; ONCOGENE; PLK GENE; PRIORITY JOURNAL; RADIATION DOSE; WILD TYPE;

BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; G2 PHASE; HUMANS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER;

EID: 2442645513     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Roshak AK, Capper EA, Imburgia C, Fornwald J, Scott G and Marshall LA: The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal 12: 405-411, 2000.
2. Toyoshima-Morimoto F, Taniguchi E and Nishida E: Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep 3: 341-348, 2002.
3. Nigg EA: Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev 2: 21-32, 2001.
4. Bakkenist CJ and Kastan MB: DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506, 2003.
5. Cortez D, Wang Y, Qin J and Elledge SJ: Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 286: 1162-1166, 1999.
6. 2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30: 285-289, 2002.
7. Matsuoka S, Huang M and Elledge SJ: Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282: 1893-1897, 1998.
8. Furnari B, Rhind N and Russell P: Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science 277: 1495-1497, 1997.
9. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H and Elledge SJ: Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Chk regulation through Cdc25. Science 277: 1497-1501, 1997.
10. Lopez-Girona A, Furnari B, Mondesert O and Russell P: Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397: 172-175, 1999.
11. Smits VAJ, Klompmaker R, Arnaud L, Rijksen G, Nigg EA and Medema RH: Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2: 672-676, 2000.
12. van Vugt MATM, Smits VAJ, Klompmaker R and Medema RH: Inhibition of polo-like kinase-1 by DNA damage occurs in an ATM- or ATR-dependent fashion. J Biol Chem 276: 41656-41660, 2001.
13. Ree AH, Bratland Å, Nome RV, Stokke T and Fodstad Ø: Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1. Oncogene 22: 8952-8955, 2003.
14. Deng CX and Brodie SG: Roles of BRCA1 and its interacting proteins. Bioessays 22: 728-737, 2000.
15. Scully R and Livingston DM: In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432, 2000.
16. Li S, Ting NSY, Zheng L, Chen PL, Ziv Y, Shiloh Y, Lee EYHP and Lee WH: Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406: 210-215, 2000.
17. Wu-Baer F and Baer R: Effect of DNA damage on a BRCA1 complex. Nature 414: 36, 2001.
18. 2-phase checkpoints after ionizing radiation. Mol Cell Biol 21: 3445-3450, 2001.
19. Lee JS, Collins KM, Brown AL, Lee CH and Chung JH: hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404: 201-204, 2000.
20. Kelm O, Wind M, Lehmann WD and Nigg EA: Cell cycle-regulated phsphorylation of the Xenopus polo-like kinase Plx1. J Biol Chem 277: 25247-25256, 2002.
21. Jang YJ, Ma S, Terada Y and Erikson RL: Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase. J Biol Chem 277: 44115-44120, 2002.
22. Uchiumi T, Longo DL and Ferris D: Cell cycle regulation of the human polo-like kinase (PLK) promoter. J Biol Chem 272: 9166-9174, 1997.
23. WAF1/CIP1/SDI1. Cell Cycle 1: 59-66, 2002.
24. Tomlinson GE, Chen TTL, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II and Gazdar AF: Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58: 3237-3242, 1998.
25. Scully R, Ganesan S, Vlasakova K, Chen J, Socolovsky M and Livingston DM: Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell 4: 1093-1099, 1999.
26. Brünner N, Frandsen TL, Holst-Hansen C, Bei M, Thompson EW, Wakeling AE, Lippman ME and Clarke R: MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res 53: 3229-3232, 1993.
27. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok Ø, Hovig E, Meza-Zepeda LA, Bruland ØS and Fodstad Ø: Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res 59: 4675-4680, 1999.
28. Yu X, Wu LC, Bowcock AM, Aronheim A and Baer R: The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem 273: 25388-25392, 1998.
29. Chinnadurai G: CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9: 213-224, 2002.
30. 2 to M transition. J Cell Biol 156; 249-259, 2002.
31. 2 DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem 276: 37166-37177, 2001.
32. Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV and Roninson IB: Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 97: 4291-4296, 2000.
33. Datta R, Hass R, Gunji H, Weichselbaum R and Kufe D: Down-regulation of cell cycle control genes by ionizing radiation. Cell Growth Differ 3: 637-644, 1992.
34. Maity A, McKenna WG and Muschel RJ: Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J 14: 603-609, 1995.
35. Holtrich U, Wolf G, Bräuninger A, Karn T, Böhme B, Rübsamen-Waigmann H and Strebhardt K: Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci USA 91: 1736-1740, 1994.
36. Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C and Strebhardt K: Prognostic significance of Polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res 59: 2794-2797, 1999.
37. Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A and Kaufmann R: Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J Cutan Pathol 29: 354-358, 2002.
38. Spänkuch-Schmitt B, Bereiter-Hahn J, Kaufmann M and Strebhardt K: Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst 94: 1863-1877, 2002.
39. Elez R, Piiper A, Kronenberger B, Kock M, Brendel M, Hermann E, Pliquett U, Neumann E and Zeuzem S: Tumor regression by combination antisense therapy against Plk1 and Bcl-2. Oncogene 22: 69-80, 2003.